Literature DB >> 6154895

Dopaminergic stimulation of prolactin release.

C Denef, D Manet, R Dewals.   

Abstract

Prolactin (PRL) secretion from anterior pituitary is believed to be under tonic inhibitory control of dopamine (DA) released from the tubero-infundibular dopaminergic neurones into the hypophysial portal blood. Inhibition of PRL release by DA seems to be mediated by sereospecific DA receptors located in PRL cells. Apomorphine and various ergot alkaloids such as bromocryptine mimic the inhibitory effect of DA both in vivo and in vitro, presumably by a direct agonist action on these 'inhibitory' receptors. We now report that PRL secretion in primary cultures of rat pituitary cells can be stimulated by DA when concentrations a thousand times lower than those required for inhibition are used. Secretion rates above basal release can also be induced by apomorphine and bromocryptine when the 'inhibitory' receptors are blocked with certain DA receptor antagonists.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6154895     DOI: 10.1038/285243a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  12 in total

Review 1.  Ion channels and signaling in the pituitary gland.

Authors:  Stanko S Stojilkovic; Joël Tabak; Richard Bertram
Journal:  Endocr Rev       Date:  2010-07-21       Impact factor: 19.871

2.  Exercise activates vagal induction of dopamine and attenuates systemic inflammation.

Authors:  Guilherme Shimojo; Biju Joseph; Roshan Shah; Fernanda M Consolim-Colombo; Kátia De Angelis; Luis Ulloa
Journal:  Brain Behav Immun       Date:  2018-10-27       Impact factor: 7.217

3.  Dopamine D-1 receptor agonist stimulation of prolactin secretion in man.

Authors:  G Fabbrini; A Braun; M M Mouradian; C A Tamminga; T N Chase
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

4.  Low dose of dopamine may stimulate prolactin secretion by increasing fast potassium currents.

Authors:  Joël Tabak; Natalia Toporikova; Marc E Freeman; Richard Bertram
Journal:  J Comput Neurosci       Date:  2007-04       Impact factor: 1.621

5.  Fibroblast growth factor-2 and epidermal growth factor modulate prolactin responses to TRH and dopamine in primary cultures.

Authors:  Carlos Spuch; Yolanda Diz-Chaves; Diego Pérez-Tilve; Federico Mallo
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

6.  Dopamine D2 receptor mediates both inhibitory and stimulatory actions on prolactin release.

Authors:  A Chang; S H Shin; S C Pang
Journal:  Endocrine       Date:  1997-10       Impact factor: 3.633

7.  Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.

Authors:  M Ishibashi; T Yamaji
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

8.  Post weaning plasma progesterone, prolactin and environmental influence in the resumption of ovarian activity in sows.

Authors:  R Pierantoni; L Zicarelli; A Crasto; M d'lstria; S Fasano; G Delrio
Journal:  J Endocrinol Invest       Date:  1983-08       Impact factor: 4.256

9.  Neuroendocrine evidence for increased responsiveness of dopamine receptors in humans following electroconvulsive therapy.

Authors:  J Balldin; A K Granérus; G Lindstedt; K Modigh; J Wålinder
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

10.  Relationships between dopamine-induced changes in cytosolic free calcium concentration ([Ca2+]i) and rate of prolactin secretion. Elevated [Ca2+]i does not indicate prolactin release.

Authors:  A Chang; S H Shin
Journal:  Endocrine       Date:  1997-12       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.